NPT
MDT icon

Nixon Peabody Trust’s Medtronic MDT Stock Holding History

Nixon Peabody Trust’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$609K Sell
7,783
-89
-1% -$7.18K 0.04% 119
2026
Q1 		$682K Sell
7,872
-462
-6% -$44.3K 0.05% 102
2025
Q4 		$801K Sell
8,334
-49
-0.6% -$4.76K 0.06% 95
2025
Q3 		$798K Sell
8,383
-2,442
-23% -$224K 0.06% 96
2025
Q2 		$944K Sell
10,825
-1,721
-14% -$146K 0.07% 89
2025
Q1 		$1.13M Sell
12,546
-37,833
-75% -$3.39M 0.1% 81
2024
Q4 		$4.02M Sell
50,379
-79,560
-61% -$6.89M 0.33% 57
2024
Q3 		$11.7M Buy
129,939
+690
+0.5% +$58K 0.97% 39
2024
Q2 		$10.2M Sell
129,249
-5,938
-4% -$487K 0.9% 44
2024
Q1 		$11.8M Buy
135,187
+4,870
+4% +$416K 1.08% 40
2023
Q4 		$10.7M Buy
130,317
+107,163
+463% +$8.17M 1.2% 36
2023
Q3 		$1.81M Buy
23,154
+950
+4% +$79.5K 1.52% 31
2023
Q2 		$1.96M Sell
22,204
-4,859
-18% -$418K 1.59% 25
2023
Q1 		$2.18M Buy
27,063
+3,161
+13% +$258K 1.53% 26
2022
Q4 		$1.86M Sell
23,902
-500
-2% -$40.5K 1.51% 33
2022
Q3 		$1.97M Sell
24,402
-12,623
-34% -$1.13M 1.67% 25
2022
Q2 		$3.32M Sell
37,025
-249
-0.7% -$25.2K 1.5% 29
2022
Q1 		$4.14M Sell
37,274
-2,035
-5% -$215K 1.42% 34
2021
Q4 		$4.07M Buy
39,309
+5,251
+15% +$608K 1.23% 39
2021
Q3 		$4.27M Buy
34,058
+737
+2% +$95.4K 1.54% 31
2021
Q2 		$4.14M Sell
33,321
-741
-2% -$93K 1.59% 32
2021
Q1 		$4.02M Buy
34,062
+170
+0.5% +$19.9K 1.63% 29
2020
Q4 		$3.97M Sell
33,892
-60
-0.2% -$6.61K 1.67% 29
2020
Q3 		$3.53M Buy
33,952
+1,073
+3% +$108K 1.62% 28
2020
Q2 		$3.02M Buy
32,879
+1,472
+5% +$141K 1.53% 31
2020
Q1 		$2.83M Sell
31,407
-1,316
-4% -$140K 1.75% 25
2019
Q4 		$3.71M Buy
32,723
+85
+0.3% +$9.33K 1.85% 25
2019
Q3 		$3.54M Buy
32,638
+1,257
+4% +$131K 1.89% 27
2019
Q2 		$3.06M Buy
31,381
+4,405
+16% +$402K 1.72% 31
2019
Q1 		$2.46M Buy
26,976
+2,745
+11% +$246K 1.61% 28
2018
Q4 		$2.2M Sell
24,231
-23
-0.1% -$2.15K 1.74% 28
2018
Q3 		$2.39M Buy
24,254
+2,068
+9% +$191K 1.63% 31
2018
Q2 		$1.9M Buy
22,186
+2,005
+10% +$167K 1.47% 35
2018
Q1 		$1.62M Buy
20,181
+220
+1% +$18.1K 1.45% 36
2017
Q4 		$1.61M Buy
19,961
+631
+3% +$50.5K 1.39% 36
2017
Q3 		$1.5M Sell
19,330
-610
-3% -$50.6K 1.37% 35
2017
Q2 		$1.77M Sell
19,940
-980
-5% -$82.6K 1.64% 31
2017
Q1 		$1.69M Sell
20,920
-642
-3% -$50.1K 1.59% 32
2016
Q4 		$1.53M Sell
21,562
-55
-0.3% -$4.32K 1.49% 32
2016
Q3 		$1.87M Sell
21,617
-2,688
-11% -$234K 1.83% 21
2016
Q2 		$2.11M Sell
24,305
-9,250
-28% -$748K 1.83% 17
2016
Q1 		$2.52M Sell
33,555
-590
-2% -$44.4K 2.24% 12
2015
Q4 		$2.63M Buy
+34,145
New +$2.57M 2.39% 11

Other funds holding MDT

FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Nixon Peabody Trust's MDT Position: Q2 2026 in Review

Nixon Peabody Trust reduced its Medtronic (MDT) stake by 1.1% in Q2 2026, selling an estimated $7.18K and leaving 7,783 shares worth $609K. The position accounts for 0.04% of the portfolio, ranked #119.

Nixon Peabody Trust first reported a position in MDT in Q4 2015 and has held it in 43 quarters since. The position peaked at $11.8M in Q1 2024. 796 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Nixon Peabody Trust held 7,783 shares of Medtronic worth $609K as of Q2 2026.
  • Nixon Peabody Trust sold 89 Medtronic shares in Q2 2026, an estimated $7.18K.
  • Medtronic made up 0.04% of Nixon Peabody Trust's portfolio in Q2 2026, its #119 holding.
  • Nixon Peabody Trust first reported a position in Medtronic in Q4 2015 and has held it in 43 quarters since.
  • Nixon Peabody Trust's Medtronic position peaked at $11.8M in Q1 2024.
  • 796 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.